Korean made Gmate COVID-19 Saliva Antigen Test Kit is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human saliva specimens. This test is an aid to early diagnosis of SARS-CoV-2 infection in patients with clinical symptoms with SARS-CoV-2 infection. â?¢ 90.9% Sensitivity, 100% Specificity â?¢ Made in Korea â?¢ Easy to Use â?¢ Currently the only imported brand approved and fully registered with governments and medical / health agencies for professional and home use. Provides initial screening result only Disclaimer: Reactive specimens must be confirmed with alternative testing method(s)
25 tests per box, CE certificate
COVID-19 Antigen Rapid Test (Saliva Lollipop) is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in Saliva samples from individuals suspected of COVID-19. Welcome to inquiry.
Covid Antigen Ag saliva rapid test card, Sensitivity: 97.1% Specificity: 99% Agreement: 99.57% 10 miuntes to get the result. MOQ for each: 500 tests, 20 tests/box,
Sensitivity (93.94%) Specificity (>99%) Results in 10 minutes CE Certificate
The COVID-19Antigen Rapid Test Cassette (Saliva) is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in saliva from individuals who are suspecte of COVID-19 by their healthcare provider. There are single pack and 25pcs products (SOFTEC COVID-19 Antigen Rapid Test (Saliva)25pcs Pack). The price of the product is determined by the number of orders.
Rapid Accurate Innovative Comfortable Lollipop style Integral This SARS-CoV-2 Antigen Kit (Saliva Pen) is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in saliva specimens from individuals who are suspected of COVID-19. The most suitable for over-the-counter (OTC) home use by laymen in a non-laboratory setting. The most widely used testing scenarios, like for school kids test. The most integral design, simple and easy use lollipop style. The fastest result deliver: result is available within only 15 minutes. Cat.No Description Package size CG123201 Goldsite SARS-CoV-2 Antigen Kit(Saliva Pen) 1T CG123207 Goldsite SARS-CoV-2Antigen Kit(Saliva Pen) 7T CG123225 Goldsite SARS-CoV-2Antigen Kit(Saliva Pen) 25T
GENEDIA W COVID-19 Ag (Saliva) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva
To help stop the spread of COVID-19, Singclean Medical has developed COVID-19 Antigen Test Kits saliva swab which is a solid phase immunochromatographic assay for the rapid, qualitative detection of antigen from COVID-19 in human saliva swab specimen. The test provides only a preliminary test result. Therefore, any reactive specimen with the COVID-19 Antigen Test kit (Colloidal Gold) must be confirmed with alternative testing method (s) and clinical findings. Advantage: Quick: results ready in 15 minutes Affordable: no need for instrument Accurate diagnostic tool for active infection Easy to administer and read results Enable testing on a massive scale Non-invasive: more comfortable than nasopharyngeal swab Warnings 1. Use fresh samples whenever possible. 2. Positive results do not rule out bacterial infection or co-infection with other viruses. 3. A negative result can occur if the quantity of the COVID-19 antigen present in the specimen is below the detection limits of the assay, or failed to collect the COVID-19 antigen. 4. Negative results do not rule out infection with COVID-19 and should not be used as the final or sole basis for treatment or patient management decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. For a more accurate test result, repeat the tests or confirmed with other testing methods and clinical findings is recommended
